With this grant, CND will support the largest study of its kind to enhance the precision and clinical utility of its Syn-One Test, which is being adopted by neurologists to improve the diagnosis of neurodegenerative disorders, notably Parkinson’s.
Continuously improving POC technologies offer benefits for patients, practices, and payors.
Small rises in troponin levels may have value as markers for subclinical heart damage and high blood pressure.
Quest Diagnostics will begin providing nonfasting cholesterol tests designed to improve the assessment of heart disease risk.
Read More
This month’s issue features a molecular diagnostics system from XimedicaDx, a clinical chemistry analyzer from Randox Laboratories, and a sorting instrument from Yaskawa Motoman.
Read MoreClinicians are using pharmacogenomic testing to identify gene-drug interactions to guide precise patient therapies.
Read MoreDavid A. Ahlquist, MD, coinventor of the Cologuard stool-based DNA screening test for colorectal cancer, discusses updated USPSTF guidelines that seek to increase screening rates.
Read MoreThe number of people living with diabetes and its prevalence are growing in all regions of the world.
Read MoreCandidates have demonstrated comparable preclinical efficacy to existing anticoagulants but with substantially lower bleeding liability.
Read More
Part two of a three-part roundtable discussing the value of diagnostics.
Read More
The DiscoveryMap platform from Myriad RBM has identified combinations of 15 protein biomarkers associated with cardiovascular events in patients with diabetes.
Read More
The biennial ASCP vacancy survey has captured a profession in transition.
Read More
Over the past decade, the number of hospital admissions for sepsis following healthcare-associated infections and community-acquired infections has increased up to three-fold.
Read More
Researchers seek to better understand the genomic basis of disease, and provide tailored care to patients.
Read More
The concept of prevention is expanding, notes principal investigator Christie Ballantyne, MD, director of the Center for Cardiovascular Disease Prevention at The Methodist Hospital.
Read MoreResearchers have found that high levels of triglycerides (blood fats) are the strongest risk factor for the most common type of stroke in older women.
Read MoreThe study found success in utilizing a new method of delivery of a potent biotechnology anti-inflammatory therapeutic. Pictured is a patient dialing a phone an hour after treatment, something he’d previously been unable to do after his stroke.
Read MoreNew research shows a long-term benefit in screening people for CRP, a marker for inflammation, even if they have normal levels of bad cholesterol, because of increased long-term risk for heart attack, stroke and death.
Read More